US 10392430
Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties
granted A61KA61K38/00A61P
Quick answer
US patent 10392430 (Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61P, A61P43/00